TNF and inflammatory bowel disease: Anti-TNF therapy has been reported to significantly reduce the risk for PD development that is otherwise associated with IBD [23], and our experimental findings here as well as other studies [15, 90, 91] support the potential of TNF to promote dopaminergic neuropathology.